Advertisement

Related Videos

Russell Szmulewitz, MD, on Alternative Dosing of Abiraterone in Prostate Cancer: Pharmacoeconomic Proof of Concept

David A. Hyman, MD, JD, on Inclusive Shared Savings

Welcome and Introduction to Vi3C

Gary L. Rosner, ScD, on Bayesian Non-Inferiority

Garth Strohbehn, MD, MPhil, on Applied Clinical Pharmacology in a Crisis: Interventional Pharmacoeconomics and COVID-19

Advertisement

Advertisement




Feb
06
Today In Oncology
Chemotherapy-Free Regimen Improves Outcomes in Newly Diagnosed Patients With Ph-Positive ALL
Early Results Show Pirtobrutinib Matches Ibrutinib in BTK Inhibitor-Naive CLL
Colorectal Cancer Liver Metastases: Transplant or Resect?
Metastasis-Directed Therapy for Oligometastatic Prostate Cancer
New European Project Cluster EARLYSCAN Launched to Advance Early Detection of Heritable Cancers
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo